- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00403676
Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is part of a national multicenter study (NOR-DMARD) that aims to measure the longterm safety and effectiveness of disease modifying therapies in inflammatory arthropathies. The Nor-Dmard study is a comparative, phase IV, longitudinal, observational study. All patients starting a DMARD regime are enrolled. Patients from two clinics (different parts of Norway) will be randomised to receive follow-up care from either a clinical nurse or a rheumatologist.
The primary outcome measure is patient satisfaction measured by Leeds Satisfaction Questionnaire.
The secondary outcome is effectiveness measured by Coping (CORS),Health related quality of life (SF-36) and Disease activity (MHAQ, DAS-28).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Trondheim, Norway, 7020
- St. Olavs Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with inflammatory arthropathies monitored after starting disease modifying antirheumatic drugs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Follow up by nurse
Patient randomized for follow-up by a nurse
|
Follow up bu a nurse
|
|
Experimental: follow up by medical doctor
Patients randomized for follow up by a medical doctor
|
Follow up by a medical doctor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
patient satisfaction
Time Frame: 12 mnths and 24 mnths
|
12 mnths and 24 mnths
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Health related quality of life
Time Frame: 12 mnths and 24 mnths
|
12 mnths and 24 mnths
|
|
Disease activity
Time Frame: 12 mnths and 24 mnths
|
12 mnths and 24 mnths
|
|
coping
Time Frame: 12 mnths and 24 mnths
|
12 mnths and 24 mnths
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Kåre Birger Hagen, PhD, Diakonhjemmet Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DiakonhjemmetS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.